This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OTHER_OR_ILLDEFINED_SITES_EXALLC for full statistics.
Malignant neoplasm of other and ill-defined sites
C3_OTHER_OR_ILLDEFINED_SITES
benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
99 |
4. Check minimum number of eventsNone |
99 |
5. Include endpointsNone |
99 |
6. Filter based on genotype QC (FinnGen only) |
99 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined sites
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)
- Secondary uncertain malignant neoplasm
- Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 99 | 27 | 72 |
| Unadjusted period prevalence (%) | 0.03 | 0.01 | 0.03 |
| Median age at first event (years) | 72.66 | 76.80 | 71.11 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 88
- Matched controls
- 880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
37.1
33
*
8000/3-C76.2
ICD-O-3
Neoplasm, malignant of abdomen, NOS
+∞
12.8
12
*
8140/3-C76.2
ICD-O-3
Adenocarcinoma, NOS, of abdomen, NOS
+∞
11.7
11
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
49.6
7.9
9
*
130
Kela drug reimbursment
Malignant tumour
5.9
7.5
21
44
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
7.4
7
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
43.5
6.9
8
*
A98
ICPC
Health maint/preventive medicine
0.3
6.6
24
495
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
15.9
6.6
10
7
8000/3-C76.1
ICD-O-3
Neoplasm, malignant of thorax, NOS
+∞
6.3
6
*
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
+∞
6.3
6
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
5
0
+∞
5.25
1.0
0.0
26.1
—
ug/l
—
5
0
35
555
0.43
3.90
28.0
23.6
84.1
89.6
umol/l
0.56
35
555
9
249
0.30
3.78
1.6
2.3
—
—
—
0
0
14
272
0.43
2.23
4.1
5.2
2.0
3.1
ug/l
0.44
14
231
18
269
0.60
1.16
1.9
2.3
93.3
87.8
pmol/l
0.15
12
142
19
276
0.61
1.08
6.5
4.4
31.3
34.3
g/l
1.00
19
248
13
208
0.57
1.08
5.8
5.4
—
—
—
0
0
16
231
0.63
0.87
3.6
3.7
—
—
—
0
0
5
98
0.48
0.83
5.6
6.0
5.4
4.9
kpa
—
5
90
0
21
0.00
0.61
0.0
1.2
—
0.1
—
0
6
0
21
0.00
0.61
0.0
2.1
—
—
—
0
0
13
95
1.42
0.46
1.6
3.2
0.8
0.8
mmol/l
0.89
13
83
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
5
80
0.61
0.37
3.6
4.2
—
—
—
0
0
7
53
1.34
0.31
1.4
1.6
482.9
436.9
nmol/l
—
7
43
18
214
0.81
0.30
1.6
2.0
144.8
289.5
u/l
0.88
18
196
16
133
1.24
0.26
3.3
2.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
29
314
0.89
0.15
9.2
5.9
17.7
11.4
umol/l
0.79
29
295
22
236
0.91
0.09
4.2
4.6
—
—
—
0
0
5
62
0.80
0.08
2.2
2.5
5.5
5.0
kpa
—
5
55
10
102
0.98
0.00
1.5
4.9
1.0
1.0
mmol/l
—
10
87
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
5
49
1.02
0.00
1.8
1.4
—
—
—
0
0
5
58
0.85
0.00
2.2
2.6
3.6
1.6
mmol/l
—
5
44
6
68
0.87
0.00
3.8
9.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
4.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.6
—
111.4
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OTHER_OR_ILLDEFINED_SITES – Malignant neoplasm of other and ill-defined sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).